Market closed
Orchestra BioMed Holdings, Inc./$OBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Ticker
$OBIO
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
70
Website
OBIO Metrics
BasicAdvanced
$106M
-
-$1.66
0.59
-
Price and volume
Market cap
$106M
Beta
0.59
52-week high
$5.04
52-week low
$2.65
Financial strength
Current ratio
4.268
Quick ratio
4.128
Long term debt to equity
48.483
Total debt to equity
50.152
Interest coverage (TTM)
-216.50%
Management effectiveness
Return on assets (TTM)
-46.90%
Return on equity (TTM)
-120.84%
Valuation
Price to revenue (TTM)
38.524
Price to book
3.2
Price to tangible book (TTM)
3.2
Price to free cash flow (TTM)
-1.999
Growth
Revenue change (TTM)
-4.42%
Earnings per share change (TTM)
12.10%
3-year revenue growth (CAGR)
49.98%
3-year earnings per share growth (CAGR)
-46.63%
OBIO News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Orchestra BioMed Holdings, Inc. stock?
Orchestra BioMed Holdings, Inc. (OBIO) has a market cap of $106M as of April 05, 2025.
What is the P/E ratio for Orchestra BioMed Holdings, Inc. stock?
The price to earnings (P/E) ratio for Orchestra BioMed Holdings, Inc. (OBIO) stock is 0 as of April 05, 2025.
Does Orchestra BioMed Holdings, Inc. stock pay dividends?
No, Orchestra BioMed Holdings, Inc. (OBIO) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Orchestra BioMed Holdings, Inc. dividend payment date?
Orchestra BioMed Holdings, Inc. (OBIO) stock does not pay dividends to its shareholders.
What is the beta indicator for Orchestra BioMed Holdings, Inc.?
Orchestra BioMed Holdings, Inc. (OBIO) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.